Arlene E Chung1,2,3, Kimberly Shoenbill2,4, Sandra A Mitchell5, Amylou C Dueck6, Deborah Schrag7, Deborah W Bruner8, Lori M Minasian5, Diane St Germain5, Ann M O'Mara5, Paul Baumgartner9, Lauren J Rogak10, Amy P Abernethy11,12, Ashley C Griffin2, Ethan M Basch1,2,3,10. 1. Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. 2. Program on Health and Clinical Informatics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. 3. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 4. Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. 5. National Cancer Institute, Rockville, Maryland, USA. 6. Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona, USA. 7. Division of Population Sciences, Department of Medical Oncology, Dana-Farber/Harvard Cancer Center, Brookline, Massachusetts, USA. 8. Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA. 9. Semantic Bits, LLC, Herndon, Virginia, USA. 10. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 11. Department of Medicine, Duke Cancer Institute, Durham, North Carolina, USA. 12. Flatiron Health, New York, New York, USA.
Abstract
OBJECTIVE: The study sought to describe patient-entered supplemental information on symptomatic adverse events (AEs) in cancer clinical research reported via a National Cancer Institute software system and examine the feasibility of mapping these entries to established terminologies. MATERIALS AND METHODS: Patients in 3 multicenter trials electronically completed surveys during cancer treatment. Each survey included a prespecified subset of items from the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Upon completion of the survey items, patients could add supplemental symptomatic AE information in a free text box. As patients typed into the box, structured dropdown terms could be selected from the PRO-CTCAE item library or Medical Dictionary for Regulatory Activities (MedDRA), or patients could type unstructured free text for submission. RESULTS: Data were pooled from 1760 participants (48% women; 78% White) who completed 8892 surveys, of which 2387 (26.8%) included supplemental symptomatic AE information. Overall, 1024 (58%) patients entered supplemental information at least once, with an average of 2.3 per patient per study. This encompassed 1474 of 8892 (16.6%) dropdowns and 913 of 8892 (10.3%) unstructured free text entries. One-third of the unstructured free text entries (32%) could be mapped post hoc to a PRO-CTCAE term and 68% to a MedDRA term. DISCUSSION: Participants frequently added supplemental information beyond study-specific survey items. Almost half selected a structured dropdown term, although many opted to submit unstructured free text entries. Most free text entries could be mapped post hoc to PRO-CTCAE or MedDRA terms, suggesting opportunities to enhance the system to perform real-time mapping for AE reporting. CONCLUSIONS: Patient reporting of symptomatic AEs using a text box functionality with mapping to existing terminologies is both feasible and informative.
OBJECTIVE: The study sought to describe patient-entered supplemental information on symptomatic adverse events (AEs) in cancer clinical research reported via a National Cancer Institute software system and examine the feasibility of mapping these entries to established terminologies. MATERIALS AND METHODS:Patients in 3 multicenter trials electronically completed surveys during cancer treatment. Each survey included a prespecified subset of items from the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Upon completion of the survey items, patients could add supplemental symptomatic AE information in a free text box. As patients typed into the box, structured dropdown terms could be selected from the PRO-CTCAE item library or Medical Dictionary for Regulatory Activities (MedDRA), or patients could type unstructured free text for submission. RESULTS: Data were pooled from 1760 participants (48% women; 78% White) who completed 8892 surveys, of which 2387 (26.8%) included supplemental symptomatic AE information. Overall, 1024 (58%) patients entered supplemental information at least once, with an average of 2.3 per patient per study. This encompassed 1474 of 8892 (16.6%) dropdowns and 913 of 8892 (10.3%) unstructured free text entries. One-third of the unstructured free text entries (32%) could be mapped post hoc to a PRO-CTCAE term and 68% to a MedDRA term. DISCUSSION: Participants frequently added supplemental information beyond study-specific survey items. Almost half selected a structured dropdown term, although many opted to submit unstructured free text entries. Most free text entries could be mapped post hoc to PRO-CTCAE or MedDRA terms, suggesting opportunities to enhance the system to perform real-time mapping for AE reporting. CONCLUSIONS:Patient reporting of symptomatic AEs using a text box functionality with mapping to existing terminologies is both feasible and informative.
Authors: Rave Harpaz; Alison Callahan; Suzanne Tamang; Yen Low; David Odgers; Sam Finlayson; Kenneth Jung; Paea LePendu; Nigam H Shah Journal: Drug Saf Date: 2014-10 Impact factor: 5.606
Authors: Amylou C Dueck; Tito R Mendoza; Sandra A Mitchell; Bryce B Reeve; Kathleen M Castro; Lauren J Rogak; Thomas M Atkinson; Antonia V Bennett; Andrea M Denicoff; Ann M O'Mara; Yuelin Li; Steven B Clauser; Donna M Bryant; James D Bearden; Theresa A Gillis; Jay K Harness; Robert D Siegel; Diane B Paul; Charles S Cleeland; Deborah Schrag; Jeff A Sloan; Amy P Abernethy; Deborah W Bruner; Lori M Minasian; Ethan Basch Journal: JAMA Oncol Date: 2015-11 Impact factor: 31.777
Authors: Ethan Basch; Bryce B Reeve; Sandra A Mitchell; Steven B Clauser; Lori M Minasian; Amylou C Dueck; Tito R Mendoza; Jennifer Hay; Thomas M Atkinson; Amy P Abernethy; Deborah W Bruner; Charles S Cleeland; Jeff A Sloan; Ram Chilukuri; Paul Baumgartner; Andrea Denicoff; Diane St Germain; Ann M O'Mara; Alice Chen; Joseph Kelaghan; Antonia V Bennett; Laura Sit; Lauren Rogak; Allison Barz; Diane B Paul; Deborah Schrag Journal: J Natl Cancer Inst Date: 2014-09-29 Impact factor: 13.506
Authors: Rave Harpaz; Santiago Vilar; William Dumouchel; Hojjat Salmasian; Krystl Haerian; Nigam H Shah; Herbert S Chase; Carol Friedman Journal: J Am Med Inform Assoc Date: 2012-10-31 Impact factor: 4.497
Authors: Janice Kim; Harpreet Singh; Kassa Ayalew; Kristina Borror; Michelle Campbell; Laura Lee Johnson; Alyson Karesh; Ni A Khin; Joanne R Less; Jerry Menikoff; Lori Minasian; Sandra A Mitchell; Elektra J Papadopoulos; Richard L Piekarz; Kevin A Prohaska; Susan Thompson; Rajeshwari Sridhara; Richard Pazdur; Paul G Kluetz Journal: Clin Cancer Res Date: 2017-12-13 Impact factor: 12.531
Authors: Ethan M Basch; Bryce B Reeve; Sandra A Mitchell; Stephen B Clauser; Lori Minasian; Laura Sit; Ram Chilukuri; Paul Baumgartner; Lauren Rogak; Emily Blauel; Amy P Abernethy; Deborah Bruner Journal: Cancer J Date: 2011 Jul-Aug Impact factor: 3.360
Authors: Ethan Basch; Stephanie L Pugh; Amylou C Dueck; Sandra A Mitchell; Lawrence Berk; Shannon Fogh; Lauren J Rogak; Marcha Gatewood; Bryce B Reeve; Tito R Mendoza; Ann M O'Mara; Andrea M Denicoff; Lori M Minasian; Antonia V Bennett; Ann Setser; Deborah Schrag; Kevin Roof; Joan K Moore; Thomas Gergel; Kevin Stephans; Andreas Rimner; Albert DeNittis; Deborah Watkins Bruner Journal: Int J Radiat Oncol Biol Phys Date: 2017-02-10 Impact factor: 7.038
Authors: Leàn Rolfes; Florence van Hunsel; Laura van der Linden; Katja Taxis; Eugène van Puijenbroek Journal: Drug Saf Date: 2017-07 Impact factor: 5.606
Authors: Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver Journal: Contemp Clin Trials Date: 2021-05-21 Impact factor: 2.261
Authors: Olalekan Lee Aiyegbusi; Fatima Isa; Derek Kyte; Tanya Pankhurst; Larissa Kerecuk; James Ferguson; Graham Lipkin; Melanie Calvert Journal: Health Qual Life Outcomes Date: 2020-06-10 Impact factor: 3.186
Authors: Cleo A Samuel; Angela B Smith; Wendi Elkins; Jennifer Richmond; Zahra Mahbooba; Ethan Basch; Antonia V Bennett; Arlene E Chung; Mattias Jonsson; Ronald C Chen; Bryce B Reeve Journal: Qual Life Res Date: 2020-02-28 Impact factor: 3.440
Authors: Chen-Yu Huang; Min Cheng; Na-Rong Lee; Hsin-Yi Huang; Wen-Ling Lee; Wen-Hsun Chang; Peng-Hui Wang Journal: Int J Environ Res Public Health Date: 2020-03-26 Impact factor: 3.390
Authors: Min Cheng; Howard Hao Lee; Wen-Hsun Chang; Na-Rong Lee; Hsin-Yi Huang; Yi-Jen Chen; Huann-Cheng Horng; Wen-Ling Lee; Peng-Hui Wang Journal: Int J Environ Res Public Health Date: 2019-11-29 Impact factor: 3.390